Literature DB >> 28262155

An exploratory study of immune markers in acute and transient psychosis.

Jayant Mahadevan1, Aparna Sundaresh2, Ravi Philip Rajkumar3, A Muthuramalingam4, Vikas Menon3, V S Negi2, M G Sridhar5.   

Abstract

The aim of this study was to look into the balance of pro-inflammatory (TNF-α, IL-6) and anti-inflammatory (TGF-β) cytokines and their association with stress, alterations in HPA axis activity and the disease severity in acute psychosis. Socio-demographic and clinical details were collected from 41 in-patients with a diagnosis of Acute and Transient Psychotic Disorder. Holmes and Rahe Stress Scale for stress in the preceding year, and Brief Psychiatric Rating Scale at baseline and follow up (4-12 weeks) for psychopathology were applied. IL-6, TNF-α (pro-inflammatory), TGF-β (anti-inflammatory) and Cortisol (morning and afternoon values) were measured at baseline and follow up. A total of 30 out of 41 cases recruited had follow up data available. The levels of IL-6 (p<0.001), TNF-α (p<0.001) and TGF-β (p<0.001) at baseline were all found to be significantly elevated compared to 42 age and gender matched healthy controls. There was a significant increase in the levels of TNF-α (p=0.020) and morning levels of cortisol (p=0.009) and a significant decrease in the levels of TGF-β (p=0.004) and afternoon levels of cortisol (p=0.043) from baseline to follow up. This study showed that there was an increased level of both pro and anti-inflammatory cytokines at baseline and a prolonged pro - inflammatory compared to anti - inflammatory response which warrants larger prospective studies and comparative studies to patients with schizophrenia and bipolar disorders.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute and transient psychotic disorders; Brief psychiatric rating scale; Cortisol; Hypothalamic-pituitary-adrenal (HPA) axis; Interleukin (IL)-6; Stress; Transforming Growth Factor (TGF)-β; Tumour Necrosis Factor (TNF)-α

Mesh:

Substances:

Year:  2016        PMID: 28262155     DOI: 10.1016/j.ajp.2016.11.010

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  6 in total

Review 1.  Acute and Transient Psychotic Disorders: Newer Understanding.

Authors:  Savita Malhotra; Swapnajeet Sahoo; Srinivas Balachander
Journal:  Curr Psychiatry Rep       Date:  2019-11-04       Impact factor: 5.285

2.  Immunoinflammatory Therapies in Psychiatry: Current Evidence Base.

Authors:  Vikas Menon; Shahul Ameen
Journal:  Indian J Psychol Med       Date:  2017 Nov-Dec

Review 3.  Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor.

Authors:  Fabiana Maria das Graças Corsi-Zuelli; Fernanda Brognara; Gustavo Fernando da Silva Quirino; Carlos Hiroji Hiroki; Rafael Sobrano Fais; Cristina Marta Del-Ben; Luis Ulloa; Helio Cesar Salgado; Alexandre Kanashiro; Camila Marcelino Loureiro
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

4.  Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia.

Authors:  Aleksandra Koricanac; Aleksandra Tomic Lucic; Mirjana Veselinovic; Danijela Bazic Sretenovic; Gorica Bucic; Anja Azanjac; Olivera Radmanovic; Mirjana Matovic; Marijana Stanojevic; Aleksandra Jurisic Skevin; Bojana Simovic Markovic; Jelena Pantic; Nebojša Arsenijevic; Gordana D Radosavljevic; Maja Nikolic; Nenad Zornic; Jelena Nesic; Nemanja Muric; Branimir Radmanovic
Journal:  Front Psychiatry       Date:  2022-07-25       Impact factor: 5.435

5.  Proteomic profile of serum from patients with schizophrenia spectrum disorders.

Authors:  Elena Dmitrieva; Liudmila Smirnova; Alexander Seregin; Victor Zgoda; Arkadij Semke; Svetlana Ivanova
Journal:  PeerJ       Date:  2022-08-30       Impact factor: 3.061

Review 6.  IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.

Authors:  Ada Ng; Wilson W Tam; Melvyn W Zhang; Cyrus S Ho; Syeda F Husain; Roger S McIntyre; Roger C Ho
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.